Literature DB >> 17352256

A role for DHX32 in regulating T-cell apoptosis.

Zaman Alli1, Yong Chen, Sarah Abdul Wajid, Bandar Al-Saud, Mohamed Abdelhaleem.   

Abstract

DHX32 is a novel putative RNA helicase with an activation-dependent pattern of expression in T-cells. To gain insight into the role of DHX32, Jurkat-DHX32 cells, a stable Jurkat T-cell line with constitutive DHX32 expression, were generated by retroviral gene transfer. There were no significant differences between control and Jurkat-DHX32 cells in terms of proliferation and response to several chemotherapeutic agents. There was an altered response of Jurkat-DHX32 cells to Fas signaling associated with down-regulation of the anti-apoptotic protein c-FLIP short. In normal peripheral blood lymphocytes, a correlation between DHX32 and c-FLIP short expression was detected in response to different T-cell specific and non-specific activation stimuli. Our results suggest that DHX32 might be involved in regulating T-cell response to certain apoptotic stimuli.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17352256

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Dynamic Bayesian testing of sets of variants in complex diseases.

Authors:  Yu Zhang; Soumitra Ghosh; Hakon Hakonarson
Journal:  Genetics       Date:  2014-09-11       Impact factor: 4.562

Review 2.  The three as: Alternative splicing, alternative polyadenylation and their impact on apoptosis in immune function.

Authors:  Davia Blake; Kristen W Lynch
Journal:  Immunol Rev       Date:  2021-08-08       Impact factor: 12.988

3.  Overexpression of DHX32 contributes to the growth and metastasis of colorectal cancer.

Authors:  Huayue Lin; Wenjuan Liu; Zanxi Fang; Xianming Liang; Juan Li; Yongying Bai; Lingqing Lin; Hanyu You; Yihua Pei; Fen Wang; Zhong-Ying Zhang
Journal:  Sci Rep       Date:  2015-03-18       Impact factor: 4.379

4.  Variation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis.

Authors:  Gabriela Avila-Pedretti; Jesús Tornero; Antonio Fernández-Nebro; Francisco Blanco; Isidoro González-Alvaro; Juan D Cañete; Joan Maymó; Mercedes Alperiz; Benjamín Fernández-Gutiérrez; Alex Olivé; Héctor Corominas; Alba Erra; Adrià Aterido; María López Lasanta; Raül Tortosa; Antonio Julià; Sara Marsal
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

5.  Silencing of DHX32 increases the proliferation of liver cancer cells.

Authors:  Min-Jing Cai; Jian-Hui Zhu; Jian-Quan He; Zhong-Ying Zhang; Xian-Ming Liang
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.